Which Share to Buy Now? Nordex with Strong Order Intake, Verbio Impresses at the CMD and Zefiro Methane Could Multiply in Value!
Plug Power Losing Hope? Renk Stuck in a Downtrend? RE Royalties Riding the AI Boom!
Nevada’s M&A Carousel Is Spinning: Newmont, Barrick Mining and Lahontan Gold Reposition Themselves
Speculative Stocks in Focus: Opportunities in Super Micro Computer, Strategic Resources and Infineon
Opportunities and Risks: The Key Levels for Deutsche Telekom, MS Industrie and HPQ Silicon
Almonty Industries, Rheinmetall, Lockheed Martin – Tungsten, Defence and a Share Price Decline That Could Open Up Opportunities
E-Mobility in Rally Mode! VW and Stellantis Face TÜV Inspections as dynaCERT, BYD and Tesla Show Steady Growth
Commented by Fabian Lorenz on October 13th, 2026 | 05:38 CEST
Which Share to Buy Now? Nordex with Strong Order Intake, Verbio Impresses at the CMD and Zefiro Methane Could Multiply in Value!
Created and published on behalf of Zefiro Methane Corp.
Should investors buy Nordex shares now? The wind turbine manufacturer surprised the market yesterday with strong order intake, potentially setting the stage for a new rally. There are also compelling reasons for a potential rally at Zefiro Methane. The company has just reported record figures and offers significant growth potential. Analysts see more than 200% upside, yet the share price has not yet reacted. Verbio shares, meanwhile, remain in a downtrend, despite the company being considered a beneficiary of high petrol prices. Attention is now focused on its US operations. Analysts were impressed by the company's recent Capital Markets Day and recommend buying Verbio shares.
Read
Commented by Fabian Lorenz on October 13th, 2026 | 05:36 CEST
Plug Power Losing Hope? Renk Stuck in a Downtrend? RE Royalties Riding the AI Boom!
A look at Renk's share chart brings no joy. Whether over four weeks, six months or 12 months, the share's performance is deep in the red. Analysts recommend buying, but momentum is lacking across the entire defence sector. The latest order does nothing to change that, even if it shows future potential. For AI to realise its full potential, it needs vast amounts of energy. Accordingly, hundreds of billions of US dollars are being invested in energy infrastructure, particularly in North America. This is precisely the market in which RE Royalties operates with an interesting business model. In its latest interview, the company looks to the future with optimism. By contrast, even Plug Power's most optimistic supporters are probably despairing by now.
Read
Commented by Nico Popp on October 13th, 2026 | 05:34 CEST
Nevada’s M&A Carousel Is Spinning: Newmont, Barrick Mining and Lahontan Gold Reposition Themselves
Within a month, the gold price fell about 7% to USD 4,136 per ounce. Despite this correction, transaction pace in Nevada's Walker Lane trend remains high. Major mining groups are using the still-attractive price level to clean up their balance sheets. At the same time, agile development companies are securing strategically important properties through targeted acquisitions. The rationale is clear: Acquiring existing ounces in the ground is often cheaper than making new discoveries. Astute investors can benefit from developments in Nevada.
Read
Commented by Tarik Dede on October 13th, 2026 | 05:31 CEST
Speculative Stocks in Focus: Opportunities in Super Micro Computer, Strategic Resources and Infineon
In recent days and weeks, rising global bond yields have not been the only source of considerable uncertainty in equity markets. Instead, the massive financing needs of tech companies are becoming increasingly apparent. SpaceX plans to raise USD 40 billion through borrowing, while Oracle and OpenAI also appear to need more money. Not least, media reports say Japan's SoftBank is trying to raise up to USD 100 billion from investors in the Middle East for its AI plans. Added to this is a very high level of concentration in the major US indices. The three largest stocks, Nvidia, Apple and Microsoft, now account for 21% of the S&P 500. Based on Q3 estimates, more than two-thirds of earnings growth in this index now comes from the AI sector. The rest of the US economy is not really performing. In such volatile periods, it is worth looking at speculative stocks. These often move disproportionately following sharp market movements and offer leverage on the respective sector. Today, we take a look at the shares of Super Micro Computer, Strategic Resources and Infineon.
Read
Commented by Stefan Bode on October 13th, 2026 | 05:29 CEST
Opportunities and Risks: The Key Levels for Deutsche Telekom, MS Industrie and HPQ Silicon
Share price movements, takeovers, new technologies and looming competition are currently changing the prospects of several listed companies. While an industrial stock attracts attention with a sharp share-price jump, a North American technology stock is focusing on critical materials and batteries. Meanwhile, a DAX heavyweight is coming under pressure from new competitors in the US mobile market. The following report highlights which factors could now shape the companies' future development.
Read
Commented by Armin Schulz on October 13th, 2026 | 05:26 CEST
Almonty Industries, Rheinmetall, Lockheed Martin – Tungsten, Defence and a Share Price Decline That Could Open Up Opportunities
Sangdong is producing tungsten again for the first time since 1993. Almonty's South Korean mine is now supplying a raw material from outside China that is urgently needed in defence and is also found in an increasing number of high-tech devices. China's export restrictions have driven up tungsten prices in the West, while demand remains strong. The same is true of defence. On September 14, Rheinmetall booked an order for tens of thousands of artillery shells, while Lockheed Martin announced a framework agreement worth up to USD 1.2 billion for tactical missiles on September 21. Yet the stock market has so far shown little reaction to these developments. All three stocks are under pressure. We therefore take a closer look at Almonty Industries, Rheinmetall and Lockheed Martin.
Read
Commented by André Will-Laudien on October 13th, 2026 | 05:24 CEST
E-Mobility in Rally Mode! VW and Stellantis Face TÜV Inspections as dynaCERT, BYD and Tesla Show Steady Growth
Donald Trump's surprise diesel deal with Vladimir Putin breaches Western sanctions, but the commitment to Ukraine stands. At the same time, Houthi attacks on Riyadh's airport are driving oil prices to unpredictable heights. With Brent above USD 100 a barrel, that is reason enough to switch powertrains! Supported by the electric vehicle environmental incentive, motorists are increasingly fleeing the price spiral at the pump, with alternative technologies in greater demand than ever. The clean transition relies heavily on e-mobility and green hydrogen as the future's ultimate energy carriers. But the energy transition does not only produce winners! While the struggling giants VW and Stellantis are deep into restructuring amid shrinking margins, agile challengers from the Far East and overseas dominate the field. Pioneer Tesla is delivering good figures, but its Chinese competitor BYD has long since overtaken it. At the same time, dynaCERT is demonstrating how highly innovative hydrogen technologies can make powertrains in heavy goods transport more energy-efficient. Investors should sharpen their focus, as the automotive market is currently reinventing itself.
Read
Commented by Lars Winter on October 13th, 2026 | 05:22 CEST
BioNxt, CrowdStrike and Shell: Three exciting stocks ahead of the next price surge
On the stock market, facts matter most. New study results, strong figures and solid operational records tend to attract investor attention and often drive share prices higher. These three stocks deserve a closer look: BioNxt Solutions is approaching its first human study, CrowdStrike has reported a record quarter, and Shell is benefiting from exceptionally high refining margins. Three very different stocks, each offering opportunities alongside distinct risks. We take a closer look at these compelling names in our stock check.
Read
Commented by Lars Winter on October 12th, 2026 | 05:45 CEST
Almonty, 2G Energy and Redcare Pharmacy: Three Exciting Stocks with Fresh Momentum
New orders, higher forecasts, and the transition from project developer to producer: The news outlook for Almonty Industries, 2G Energy, and Redcare Pharmacy has improved significantly recently. The three companies serve completely different markets. What they have in common is that they must now translate high expectations into measurable growth. We take a closer look at these three stocks.
Read
Commented by Stefan Bode on October 12th, 2026 | 05:42 CEST
Allied Raw Materials and the Battle for a Turnaround: adesso, INDUS, Strategic Resources
The race for competitive technologies, strategic raw materials and the right moment on the chart is driving companies and investors alike. One stock in today's report is targeting the key resistance line again for the first time in months after a price decline; another must prove, after a spectacular rally, that its profit jump is more than a one-off commodity effect. A third, barely noticed stock is betting on vanadium for green steel and fast-charging batteries. Whether a comeback, a test or a quiet beacon of hope, opportunities and risks must be carefully weighed up.
Read
Commented by Jens Castner on October 12th, 2026 | 05:39 CEST
Drill Deep, Plug Wells, Manage Risk: How Daldrup, Zefiro and Munich Re Make Money from Climate Protection
Created and Published on Behalf of Zefiro Methane Corp.
What was long considered a quiet environmental problem is growing into a market whose size in the United States alone is estimated at up to USD 280 billion. In Germany, thousands of abandoned oil and gas wells lie in the ground, while in the US there are millions. Many pollute the atmosphere with methane, a climate-killing gas. For drilling services provider Daldrup & Söhne, plugging old wells represents a new business line, although growth is being driven primarily by the geothermal energy boom. Canadian specialist Zefiro Methane, by contrast, focuses entirely on the remediation of orphaned wells in the US and generates additional revenue from CO₂ credits. Munich Re is active in both markets.
Read
Commented by Matthias Schomber on October 12th, 2026 | 05:37 CEST
Infineon Slides, Chinese Anchor Investor at Puma, and a Potential Chart Breakout at HPQ Silicon! Where Are the Opportunities for Your Portfolio?
Nervousness is rising across the markets. Share prices are being driven by major investors taking stakes, the AI boom, political statements, and the latest developments in the war. While chip giant Infineon is benefiting from a massive AI boost despite market turbulence, China's Anta is gaining influence at Puma and could give the sporting goods manufacturer exactly the fresh momentum it needs. Meanwhile, Canadian technology company HPQ Silicon is approaching a critical technical resistance level. A breakout could open the door to significant upside potential. What opportunities do these three very different stocks offer, and where might an entry point be worthwhile?
Read
Commented by Fabian Lorenz on October 12th, 2026 | 05:30 CEST
After 600% Gains with Moderna! Cardiol Therapeutics Poised for a Revaluation - Analysts See Significant Upside Potential
With gains of more than 600%, Moderna is the Nasdaq’s best-performing stock so far this year. Much of its future growth potential may already be priced in, prompting Citigroup to recommend selling shares in the mRNA specialist. Analysts, however, see significant upside potential in another biotech company: Cardiol Therapeutics. The Canadian biotechnology company focuses on inflammatory heart diseases, and its lead drug candidate, CardiolRx™, is already in Phase 3 clinical trials. Following strong Phase 2 data, the stock more than doubled between July and September. After a subsequent pullback, could this present an attractive entry opportunity? In a recent interview, the CEO explains why he remains optimistic. Two research firms recommend buying the stock and see the potential for a multiple-fold increase in its share price.
Read
Commented by Carsten Mainitz on October 12th, 2026 | 05:28 CEST
Don’t Miss Out! Cancer Research and Comeback Potential: Vidac Pharma, Bayer and Evotec in Focus!
New cancer therapies are targeting major medical breakthroughs. For investors, however, the key question is when scientific progress will begin to translate into rising share prices. Vidac Pharma is at a particularly exciting stage in its development. The company is awaiting crucial clinical trial data that could validate its innovative approach to cancer cell metabolism and mark a major milestone. Bayer is expanding its oncology business but must also contend with a range of challenges. Meanwhile, Evotec needs to prove it can turn its research, technology platforms, and strategic partnerships into profitable business opportunities while rebuilding lost investor confidence. Which developments could now trigger a revaluation of these three stocks?
Read
Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST
Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom
When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.
Read